Follow

Newsletter

MolecularCloud issues the monthly newsletter to promote latest news and research advances from Cloud Scientists.

Imagine being vaccinated against influenza with a single visit to your doctor. She simply gives you a “magic shot” and then tells you that you won’t see her again, at least not for flu, for the rest of your life. Sound like a Disney movie? Don’t tell Dr. Masaru Kanekiyo ...Learn More


With hundreds of on-going clinical trials and 5 FDA-approved drugs to date, CAR-T cell therapy is one of the most attractive immunotherapies that have got the most attention and advanced the furthest in clinical development. Nevertheless, despite remarkable success in the ...Learn More


Malaria is primarily considered as an infectious and life-threatening disease, causing fever, chills, lethargy, nausea, vomiting, diarrhea and other flu-like symptoms in humans. Female Anopheles mosquitos are merely extremely competent vectors of the Plasmodium parasite, the true ...Learn More


Antibody drug conjugates (ADCs) for cancer treatments refer to a relatively new type of cancer immunotherapy that applies monoclonal antibodies to locate specific malignant cells and meanwhile relies on chemotherapeutic drugs to destroy them. In an ADC, the antibody and the drug ...Learn More


The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has attracted constant attention while the toll of deaths and infections keeps growing around the world. In order to meet the urgent demand of a SARS-CoV-2 vaccine, different kinds of immunization ...Learn More


About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2021 MolecularCloud